- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07812025
Comparing Outcomes of Labrum Preservation vs Excision in Primary Total Hip Arthroplasty
Labral Excision vs Preservation in Primary Total Hip Arthroplasty: A Prospective Randomized Controlled Trial
This research is being done to determine whether removing or preserving the acetabular labrum, a ring of cartilage around the hip socket, during hip replacement surgery affects post-operative outcomes, operative time, or ease of placing the hip implant.
Both techniques (labrum removal and labrum preservation) are commonly performed by surgeons during total hip arthroplasty (THA). However, there is no definitive evidence showing whether one approach is better than the other. The goal of this study is to compare recovery and surgical factors between these two routinely used methods.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Georgia
-
Sandy Springs, Georgia, United States, 30328
- Total Joint Surgery Center Atlanta
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age ≥ 18 years.
- Indication for primary unilateral total hip arthroplasty for osteoarthritis (Tonnis grade ≥2 or surgeon's standard indication).
- Able to provide informed consent and complete PROMs in English (or validated local language instruments).
Exclusion Criteria:
- Prior ipsilateral hip replacement or resurfacing.
- Active infection or inflammatory arthritis where labral management is judged by the surgeon to be non-standard.
- Severe acetabular bone loss or deformity requiring custom implants or complex reconstruction (Crowe III/IV dysplasia).
- Planned simultaneous bilateral hip arthroplasty.
- Preoperative heterotopic ossification.
- Cognitive impairment preventing consent or completion of PROMs.
- Patients for whom the surgeon believes leaving the labrum would be unsafe (e.g., gross interposed soft tissue preventing any reasonable cup placement without removal)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Group A: Labrum Excision
This group has their labrum excised, with is the standard of care for THA.
|
The acetabular labrum will be removed during surgery, prior to final cup placement.
|
|
Experimental: Group B: Labrum Preservation
The experimental group to test recovery outcomes from preserving the labrum.
|
The acetabular labrum will be left in place during surgery unless it physically prevents proper implant seating, in which case it may be trimmed as necessary.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Veterans RAND 12-Item Health Survey (VR-12) Physical Component Score (PCS)
Time Frame: Baseline (preoperative), 6 weeks, 6 months, and 1 year postoperatively
|
Change in physical health status measured by the Veterans RAND 12-Item Health Survey (VR-12), Physical Component Score.
Scores range from 0 to 100, with higher scores indicating better physical health status.
Compared between labrum excision and labrum preservation groups.
|
Baseline (preoperative), 6 weeks, 6 months, and 1 year postoperatively
|
|
Veterans RAND 12-Item Health Survey (VR-12) Mental Component Score (MCS)
Time Frame: Baseline (preoperative), 6 weeks, 6 months, and 1 year postoperatively
|
Change in mental health status measured by the Veterans RAND 12-Item Health Survey (VR-12), Mental Component Score.
Scores range from 0 to 100, with higher scores indicating better mental health status.
Compared between labrum excision and labrum preservation groups.
|
Baseline (preoperative), 6 weeks, 6 months, and 1 year postoperatively
|
|
Procedure Satisfaction (5-Point Likert Scale)
Time Frame: 12 weeks postoperatively
|
Patient-reported satisfaction with the surgical procedure, assessed via a 5-point Likert scale at 12 weeks postoperatively.
Scores range from 1 (Very Dissatisfied) to 5 (Very Satisfied), with higher scores indicating greater satisfaction.
Compared between labrum excision and labrum preservation groups.
|
12 weeks postoperatively
|
|
Numeric Pain Rating Scale (NPRS)
Time Frame: Baseline (preoperative), 6 weeks, 6 months, and 1 year postoperatively
|
Patient-reported pain intensity measured by the Numeric Pain Rating Scale, an 11-point scale ranging from 0 to 10, with higher scores indicating worse (greater) pain.
Compared between labrum excision and labrum preservation groups.
|
Baseline (preoperative), 6 weeks, 6 months, and 1 year postoperatively
|
|
HOOS, JR. (Hip Disability and Osteoarthritis Outcome Score for Joint Replacement)
Time Frame: Baseline (preoperative), 6 weeks, 6 months, and 1 year postoperatively
|
Change in hip-specific patient-reported outcome measured by the Hip disability and Osteoarthritis Outcome Score, Joint Replacement (HOOS, JR.).
Scores range from 0 to 100, with higher scores indicating better hip function and less disability.
Compared between labrum excision and labrum preservation groups.
|
Baseline (preoperative), 6 weeks, 6 months, and 1 year postoperatively
|
|
Forgotten Joint Score-12 (FJS-12)
Time Frame: Baseline (preoperative), 6 weeks, 6 months, and 1 year postoperatively
|
Change in joint awareness during daily activities measured by the Forgotten Joint Score-12 (FJS-12).
Scores range from 0 to 100, with higher scores indicating better outcomes (less awareness of the joint, i.e., the joint is more "forgotten").
Compared between labrum excision and labrum preservation groups.
|
Baseline (preoperative), 6 weeks, 6 months, and 1 year postoperatively
|
|
Intraoperative Soft-Tissue/Labral Interference with Cup Position
Time Frame: Intraoperative (at time of surgery)
|
Surgeon-judged determination (yes/no) of whether soft tissue or the labrum interfered with acetabular cup positioning during the procedure, compared between groups.
|
Intraoperative (at time of surgery)
|
|
Protocol Deviation Rate (Labral Removal in Preservation Arm)
Time Frame: Intraoperative (at time of surgery)
|
Incidence of labral removal in patients randomized to the labrum preservation arm, performed per the predefined protocol deviation criteria when needed for safe cup or liner seating.
These cases remain in the intention-to-treat analysis and are also assessed in a per-protocol sensitivity analysis.
|
Intraoperative (at time of surgery)
|
|
Operative Time
Time Frame: Intraoperative (at time of surgery)
|
Total surgical time in minutes from skin incision to skin closure, recorded from the operative record and compared between labrum excision and labrum preservation groups.
|
Intraoperative (at time of surgery)
|
|
Total Fluoroscopy Time
Time Frame: Intraoperative (at time of surgery)
|
Total fluoroscopy time recorded during the surgical procedure, compared between labrum excision and labrum preservation groups.
|
Intraoperative (at time of surgery)
|
|
Incidence of Supplemental Acetabular Screw Use
Time Frame: Intraoperative (at time of surgery)
|
Proportion of patients requiring supplemental acetabular screws for component fixation, compared between labrum excision and labrum preservation groups.
|
Intraoperative (at time of surgery)
|
|
Estimated Blood Loss (EBL)
Time Frame: Intraoperative (at time of surgery)
|
Estimated intraoperative blood loss, compared between labrum excision and labrum preservation groups.
|
Intraoperative (at time of surgery)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Iliopsoas Pain
Time Frame: Within 90 days postoperatively
|
Incidence of iliopsoas pain reported within 90 days after surgery, compared between labrum excision and labrum preservation groups.
|
Within 90 days postoperatively
|
|
Instability
Time Frame: 90 days and 1 year postoperatively
|
Incidence of postoperative hip instability, compared between labrum excision and labrum preservation groups.
|
90 days and 1 year postoperatively
|
|
Dislocation
Time Frame: 90 days and 1 year postoperatively
|
Incidence of postoperative hip dislocation, compared between labrum excision and labrum preservation groups.
|
90 days and 1 year postoperatively
|
|
Periprosthetic Joint Infection (PJI)
Time Frame: 90 days and 1 year postoperatively
|
Incidence of periprosthetic joint infection, compared between labrum excision and labrum preservation groups.
|
90 days and 1 year postoperatively
|
|
Reoperation
Time Frame: 90 days and 1 year postoperatively
|
Incidence of reoperation for any cause, compared between labrum excision and labrum preservation groups.
|
90 days and 1 year postoperatively
|
|
All-Cause Revision
Time Frame: 90 days and 1 year postoperatively
|
Incidence of revision surgery for any cause, compared between labrum excision and labrum preservation groups.
|
90 days and 1 year postoperatively
|
|
Wound Complications
Time Frame: 90 days and 1 year postoperatively
|
Incidence of postoperative wound complications, compared between labrum excision and labrum preservation groups.
|
90 days and 1 year postoperatively
|
|
Venous Thromboembolism (DVT/PE)
Time Frame: 90 days and 1 year postoperatively
|
Incidence of venous thromboembolism, including deep vein thrombosis and pulmonary embolism, compared between labrum excision and labrum preservation groups.
|
90 days and 1 year postoperatively
|
|
Readmission
Time Frame: 90 days and 1 year postoperatively
|
Incidence of hospital readmission, compared between labrum excision and labrum preservation groups.
|
90 days and 1 year postoperatively
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- NSH1444
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.